-
Something wrong with this record ?
Preparation of pellets with controlled release of glucose as prevention of hypoglycaemia in paediatric patients
A. Franc, J. Muselík, D. Sabadková, D. Neumann,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT14479
MZ0
CEP Register
- MeSH
- Child MeSH
- Glucose chemistry MeSH
- Hypoglycemia prevention & control MeSH
- Drug Delivery Systems * MeSH
- Delayed-Action Preparations chemistry MeSH
- Humans MeSH
- Solubility MeSH
- Drug Liberation MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Hypoglycaemic episodes represent serious and frequent complications of type 1 and 2 diabetes. Theoretically, the risk of hypoglycaemic states can be affected by a dosage form based on a food supplement containing a delayed release formulation of glucose. The release of glucose should compensate for balance the peak effect of an antidiabetic treatment. In clinical practice, a diet with fibre and grains is recommended and patients are broadly educated in the topic of low and high glycaemic indexes to achieve the same effect. However, a precisely-timed release of carbohydrates can favourably target expected hypoglycaemia and concurrently decrease carbohydrate content. To study the possibility of preparing the dosage form with controlled-release carbohydrates, a dosage form of pellets containing four osmotically active substances coated by a membrane created of ethylcellulose was prepared. These pellets can be administered in a mixture with liquid or semisolid food. The resulting dissolution profiles for selected compositions showed that delayed release can be achieved for 120, 240 and 360min in vitro, representing an ideal delay for clinical purposes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010412
- 003
- CZ-PrNML
- 005
- 20190517104659.0
- 007
- ta
- 008
- 160408s2015 ne f 000 0|engg|
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2015.03.007 $2 doi
- 024 7_
- $a 10.1016/j.ejps.2015.03.007 $2 doi
- 035 __
- $a (PubMed)25805346
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Franc, Aleš, $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1/3, 612 00 Brno, Czech Republic. Electronic address: franca@vfu.cz. $d 1968- $7 mzk2008479726
- 245 10
- $a Preparation of pellets with controlled release of glucose as prevention of hypoglycaemia in paediatric patients / $c A. Franc, J. Muselík, D. Sabadková, D. Neumann,
- 520 9_
- $a Hypoglycaemic episodes represent serious and frequent complications of type 1 and 2 diabetes. Theoretically, the risk of hypoglycaemic states can be affected by a dosage form based on a food supplement containing a delayed release formulation of glucose. The release of glucose should compensate for balance the peak effect of an antidiabetic treatment. In clinical practice, a diet with fibre and grains is recommended and patients are broadly educated in the topic of low and high glycaemic indexes to achieve the same effect. However, a precisely-timed release of carbohydrates can favourably target expected hypoglycaemia and concurrently decrease carbohydrate content. To study the possibility of preparing the dosage form with controlled-release carbohydrates, a dosage form of pellets containing four osmotically active substances coated by a membrane created of ethylcellulose was prepared. These pellets can be administered in a mixture with liquid or semisolid food. The resulting dissolution profiles for selected compositions showed that delayed release can be achieved for 120, 240 and 360min in vitro, representing an ideal delay for clinical purposes.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a léky s prodlouženým účinkem $x chemie $7 D003692
- 650 12
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a glukosa $x chemie $7 D005947
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemie $x prevence a kontrola $7 D007003
- 650 _2
- $a rozpustnost $7 D012995
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Muselík, Jan $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1/3, 612 00 Brno, Czech Republic. Electronic address: muselikj@vfu.cz. $7 xx0100243
- 700 1_
- $a Sabadková, Dana $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1/3, 612 00 Brno, Czech Republic. Electronic address: sabadkova.d@gmail.com. $7 _AN080394
- 700 1_
- $a Neumann, David, $u University Hospital, Department of Paediatrics, Sokolská 581, 500 05 Hradec Králové, Czech Republic. Electronic address: david.neumann@fnhk.cz. $d 1973- $7 xx0079752
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 75, č. - (2015), s. 72-80
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25805346 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20190517104808 $b ABA008
- 999 __
- $a ok $b bmc $g 1113841 $s 934780
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 75 $c - $d 72-80 $e 20150321 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- GRA __
- $a NT14479 $p MZ0
- LZP __
- $a Pubmed-20160408